Scotts Miracle-Gro Faces Critical Earnings Test

This Wednesday brings a pivotal moment for Scotts Miracle-Gro as the company prepares to release its Q4 2025 financial results. Market participants anticipate these figures could significantly influence the stock’s trajectory. Current projections point to a loss of $1.91 per share, with revenue expected to reach approximately $397 million.

Institutional Positioning Shows Dramatic Shifts

Recent filings reveal substantial repositioning among major investors:
– Teacher Retirement System of Texas expanded its stake by a remarkable 1,487%
– FMR LLC increased its position by 5,793%
– Conversely, KAYNE ANDERSON slashed its holdings by 99%

These institutional moves coincide with conflicting insider activity. A company director disposed of 56,633 shares at $63.02 each, totaling $3.5 million in value. Meanwhile, the chief financial officer demonstrated confidence by acquiring 1,790 shares worth approximately $110,000.

Technical Indicators Paint Challenging Picture

The stock’s technical positioning remains under pressure:
* Current trading sits below both the 50-day moving average of $58.58 and the 200-day average of $60.33
* The 52-week range spans from $45.61 to $93.90
* Market sentiment gauges show “Fear” with a reading of 39 on the Fear & Greed Index
* The equity has closed higher on just 10 of the past 30 trading sessions

Should investors sell immediately? Or is it worth buying Scotts Miracle-Gro?

Analyst Outlook Remains Cautious

Market experts maintain restrained expectations. The projected quarterly loss marks a stark reversal from the previous quarter, when Scotts Miracle-Gro surpassed profit forecasts with earnings of $2.59 per share, despite a 1.2% revenue decline.

Recent price target adjustments reflect this cautious stance:
– UBS reduced its target to $62
– Wells Fargo established a $67 target
– The consensus price objective stands near $69

With expectations set low, Wednesday’s earnings announcement could present an opportunity for positive surprise. The convergence of wary analysts, contradictory insider trading patterns, and substantial institutional realignment makes this earnings release a potentially defining moment for the gardening specialist’s stock.